Group 1 - Concentra Group Holdings Parent, Inc. (NYSE:CON) is considered a cheap healthcare stock with a "Buy" rating from all seven analysts, indicating a median price target of $29, which suggests an upside potential of 48.95% from the current price [1] - Following the announcement of its third-quarter results, analysts reaffirmed their bullish outlook, with Mizuho Securities maintaining a Buy rating and a price target of $28, while Bank of America Securities also maintained a Buy rating [2] - In the third quarter, Concentra reported a 17% increase in revenue, an 8.9% increase in net income, and a 17.1% increase in adjusted EBITDA, driven by growth in patient volumes and revenue per visit [3]